Dealing with vitiligo? Join our clinical trial exploring an investigational treatment aimed at restoring skin pigment. Access expert care and help shape the future of vitiligo treatment.
Frequently asked questions
Am I the right age to join this study?
You may qualify if you are between 18 and 65 years old.
What type of vitiligo do I need to have?
This study is for individuals with nonsegmental vitiligo, affecting at least 5% but no more than 50% of their body.
How do you measure if I qualify based on my vitiligo?
Your vitiligo will be assessed using specific scoring tools (F-VASI and T-VASI). You may be eligible if your scores meet the required thresholds.
What are the pregnancy and birth control requirements?
If you could become pregnant, you must use highly effective birth control during the study and for 10 days after your last dose. Men also need to use effective contraception.
What if I’m on hormonal birth control?
You may still qualify, but additional precautions like using a second form of contraception (e.g., condoms) are recommended due to possible interactions with the study medication.
What else is expected of me?
You must give written informed consent, be willing to use digital tools, and be able to follow all trial instructions, including study visits and medication schedules.
What the clinic will ask you
Encore Medical Research's own pre-screening questions. You answer them when you apply — they go to the clinic only.
- Are you between 18 and 65 years old?UnsureNoYes
- Do you have any serious or unstable health conditions (heart, liver, kidney, lung, psychiatric, or autoimmune disorders)?YesNoUnsure
- Do you have hepatitis B, hepatitis C, or HIV?YesNoUnsure
- Does your vitiligo cover between 5% and 50% of your body, including your face?UnsureYesNo
- Have you been diagnosed with nonsegmental vitiligo by a healthcare provider?UnsureNoYes
- Have you ever had tuberculosis (TB) or tested positive for latent TB?YesNoUnsure
- Have you had phototherapy, laser therapy, or tanned excessively in the past 8 weeks?UnsureYesNo
- Have you used any of the following treatments in the past 4 to 6 months?TYK2 or JAK inhibitors like deucravacitinib, tofacitinibNone of the aboveRituximab or other immune cell–depleting drugsBiologics like ustekinumab, secukinumab, guselkumab, adalimumab, infliximab
